Click a journal cover to visit the home page:
A MEDLINE-indexed peer-reviewed journal providing expert commentary on the development, application, and clinical effectiveness of new vaccines. Topics include vaccine technology, vaccine adjuvants, prophylactic vaccines, and therapeutic vaccines. It offers accelerated publication.
A MEDLINE-indexed, peer-reviewed journal providing the latest research on the performance of new therapeutic and diagnostic modalities in clinical immunology. This journal offers accelerated publication.
More Top Research:
The devastating Coronavirus Disease 2019 (COVID-19) pandemic indicates that early detection of candidates with pandemic potential is vital. However, comprehensive metagenomic sequencing of the total microbiome is not practical due to the astronomical and rapidly evolving numbers and species of micro-organisms.
Current WHO/UNICEF estimates of routine childhood immunization coverage reveal the largest sustained decline in uptake in three decades with pronounced setbacks across Africa. Although the COVID-19 pandemic has induced significant supply and delivery disruptions, the impact of the pandemic on vaccine confidence is less understood.
Vaccine hesitancy is among the top 10 threats to global health, according to the World Health Organization (WHO). In this exploration, we delve into ChatGPT capacity to generate opinions on vaccine hesitancy by interrogating this AI chatbot for the 50 most prevalent counterfait messages, false and true contraindications, and myths circulating on the internet regarding vaccine safety.
A number of vaccines have now been developed against COVID-19. Differences in reactogenicity and safety profiles according to the vaccine technologies employed are becoming apparent from clinical trials.
Need a hand in picking a journal?
Consider using our Journal Suggester.
Step 1: Paste in the full abstract of your article. The suggestions will be more accurate if you use a full abstract containing relevant keywords.
Step 2: Click on ‘Reveal suggested journals’ to see a short description of the journal and some citation and speed metrics.
Go Beyond with Open Access
Publishing open access increases the visibility and readership of your research, helping you make an impact beyond your field. We offer a wide range of publishing options where you can choose to publish fully open access (OA) or hybrid. Many Taylor & Francis policies and services are available to support you in making choices that lead to more open scholarly communications.